SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 26, 2021 for Shanghvi Finance Pvt Ltd SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 26, 2021 for Raksha Valia
Sun Pharma recalls 50,868 bottles of diabetes drug Metformin HCl in US
Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA). SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Change in Directorate
1. Appointment of Dr. Pawan Goenka (DIN: 00254502) as an Additional Independent Director of the Company w.e.f. May 21, 2021. 2. Appointment of Ms. Rama Bijapurkar (DIN: 00001835) as an Additional Independent Director of the Company w.e.f. May 21, 2021. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Sun Pharma Advanced announces positive results from phase 3 clinical trial; share price falls nearly 9%
The share touched a 52-week high of Rs 248 and a 52-week low of Rs 122.75 on 12 May, 2021 and 18 May, 2020, respectively.
SPARC to raise 1,201 cr from promoter, 34 others
The board of director of Sun Pharma Advanced Research Company Ltd on Wednesday approved a proposal to raise up to 1,200.97 crore to Dilip Shantilal S